Harbour BioMed
Peter Moesta, Ph.D., has served on the scientific advisory board since December 2016. He oversaw the development, production and worldwide launch of important medicines, such as Humira, Yervoy and Opdivo. Dr. Moesta previously served in executive roles at Bristol-Myers Squibb.
This person is not in the org chart
This person is not in any teams
This person is not in any offices